The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts
Abstract
A nine-membered panel of experts was asked to determine expert opinions of mortality risks associated with use of low-nitrosamine smokeless tobacco (LN-SLT) marketed for oral use. A modified Delphi approach was employed. For total mortality, the estimated median relative risks for individual users of LN-SLT were 9% and 5% of the risk associated with smoking for those ages 35 to 49 and ≥50 years, respectively. Median mortality risks relative to smoking were estimated to be 2% to 3% for lung cancer, 10% for heart disease, and 15% to 30% for oral cancer. Although individual estimates often varied between 0% and 50%, most panel members were confident or very confident of their estimates by the last round of consultation. In comparison with smoking, experts perceive at least a 90% reduction in the relative risk of LN-SLT use. The risks of using LN-SLT products therefore should not be portrayed as comparable with those of smoking cigarettes as has been the practice of some governmental and public health authorities in the past. Importantly, the overall public health impact of LN-SLT will reflect use patterns, its marketing, and governmental regulation of tobacco products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Research guidelines for the Delphi survey technique
Hasson, F. (2000) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2000.01567.x · Cited by 5,951
Effect of smokeless tobacco (snus) on smoking and public health in Sweden
Foulds, J., Ramstrom, L., Burke, M., & Fagerström, K. (2003) · Tobacco Control · doi:10.1136/tc.12.4.349 · Cited by 471
Cited by
Progress and Challenges in Selected Areas of Tobacco Carcinogenesis
Hecht, S. S. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7002068 · Cited by 282
Interventions to reduce harm from continued tobacco use
Lindson-Hawley, N., Hartmann-Boyce, J., Fanshawe, T. R., Begh, R., Farley, A., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005231.pub3 · Cited by 273
Current advances in research in treatment and recovery: Nicotine addiction
Prochaska, J. J., & Benowitz, N. L. (2019) · Science Advances · doi:10.1126/sciadv.aay9763 · Cited by 219
Snus: a compelling harm reduction alternative to cigarettes
Clarke, E., Thompson, K., Weaver, S., Thompson, J., & O’Connell, G. (2019) · Harm Reduction Journal · doi:10.1186/s12954-019-0335-1 · Cited by 133
Lund, K. E., Scheffels, J., & McNeill, A. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03122.x · Cited by 75
Metadata
- Authors
- Levy, D. T., Mumford, E. A., Cummings, K. M., Gilpin, E. A., Giovino, G., Hyland, A., Sweanor, D., & Warner, K. E.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2004-12-01
- Volume
- 13
- Issue
- 12
- Pages
- 2035-2042
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2117329848
- Cited by
- 238
- References
- 2
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts. https://app.cochat.ai/papers/10.1158/1055-9965.2035.13.12
- The paper
- Levy, D. T., Mumford, E. A., Cummings, K. M., Gilpin, E. A., Giovino, G., Hyland, A., Sweanor, D., & Warner, K. E. (2004). The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product Compared with Smoking Cigarettes: Estimates of a Panel of Experts. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.2035.13.12
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.